Literature DB >> 11514960

Enumeration of CD34+ cells in cord blood: a variation on a single-platform flow cytometric method based on the ISHAGE gating strategy.

A M Brocklebank1, R L Sparrow.   

Abstract

Single-platform flow cytometric absolute cell counting protocols provide increased robustness for CD34+ cell enumeration by limiting potential sources of imprecision. However, samples with any cellular fragmentation or debris, such as cord blood samples, provide challenges for these assays. We describe a simple, robust absolute CD34+ cell counting protocol, suitable for cord blood, using TRUCOUNT absolute count tubes (BD Biosciences, San Jose, CA) and a modified ISHAGE (International Society for Hematotherapy and Graft Engineering) gating strategy. An advantage of TRUCOUNT tubes is that each tube is supplied with a known number of lyophilized fluorescent beads. The method includes no-wash fixative-free ammonium chloride red blood cell lysis and the viability dye, 7-amino actinomycin D, to exclude dead cells. The threshold was set on CD45 expression in the FL1 channel and an exclusion gate in the forward scatter channel reduced debris. No manual adjustment of the gating regions was required, even for samples in less than optimal condition. Comparison of the TRUCOUNT-ISHAGE protocol with the original dual-platform ISHAGE assay (n = 30) and the single-platform ISHAGE protocol using Flow-Count Fluorospheres (Beckman Coulter, Fullerton, CA; n = 22) showed high correlation (R(2) = 0.949 and 0.989, respectively) and no significant difference or bias for samples ranging from 22 to 600 CD34+ cells per microliter. Results are presented that demonstrate the detrimental effect of a fixative-containing lysis reagent when used in a lyse-and-wash procedure. The TRUCOUNT-ISHAGE protocol combines the attributes of TRUCOUNT tubes and the ISHAGE gating strategy to provide a single-platform protocol capable of achieving readily standardization of CD34+ cell enumeration. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514960     DOI: 10.1002/cyto.1136

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  12 in total

1.  Immunophenotyping of hematopoietic progenitor cells: Comparison between cord blood and adult mobilized blood grafts.

Authors:  Nesrine Ben Azouna; Lamia Berraeis; Zohra Regaya; Faouzi Jenhani
Journal:  World J Stem Cells       Date:  2011-11-26       Impact factor: 5.326

2.  Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF.

Authors:  L Farina; A Guidetti; F Spina; L Roncari; P Longoni; F Ravagnani; C Carlo-Stella; P Corradini
Journal:  Bone Marrow Transplant       Date:  2013-12-09       Impact factor: 5.483

3.  CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34(+) hemopoietic progenitors cells.

Authors:  F M Rossi; A Zucchetto; E Tissino; M Dal Bo; R Bomben; C Caldana; F Pozzo; G Del Poeta; D Rossi; G Gaidano; V Gattei
Journal:  Leukemia       Date:  2013-11-08       Impact factor: 11.528

Review 4.  Stem cell transplants at childbirth.

Authors:  Paul R Sanberg; Dong-Hyuk Park; Cesar V Borlongan
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

5.  Fully automated, clinical-grade bone marrow processing: a single-centre experience.

Authors:  Benedetta Mazzanti; Serena Urbani; Simone Dal Pozzo; Paola Bufano; Lara Ballerini; Alessia Gelli; Irene Sodi; Irene Donnini; Massimo Di Gioia; Stefano Guidi; Julien Camisani; Riccardo Saccardi
Journal:  Blood Transfus       Date:  2016-09-27       Impact factor: 3.443

6.  The Royan Public Umbilical Cord Blood Bank: Does It Cover All Ethnic Groups in Iran Based on HLA Diversity?

Authors:  Saeideh Ebrahimkhani; Shirin Farjadian; Marzieh Ebrahimi
Journal:  Transfus Med Hemother       Date:  2014-02-17       Impact factor: 3.747

7.  GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells.

Authors:  Mayumi Kamata; Yoko Okitsu; Tohru Fujiwara; Masahiko Kanehira; Shinji Nakajima; Taro Takahashi; Ai Inoue; Noriko Fukuhara; Yasushi Onishi; Kenichi Ishizawa; Ritsuko Shimizu; Masayuki Yamamoto; Hideo Harigae
Journal:  Haematologica       Date:  2014-08-22       Impact factor: 9.941

8.  Human Leukocyte Antigen and Red Blood Cells Impact Umbilical Cord Blood CD34+ Cell Viability after Thawing.

Authors:  Diana Vanegas; Cristian-Camilo Galindo; Iván-Aurelio Páez-Gutiérrez; Lorena-Xiomara González-Acero; Pavel-Tiberio Medina-Valderrama; Juan-Camilo Lozano; Bernardo Camacho-Rodríguez; Ana-María Perdomo-Arciniegas
Journal:  Int J Mol Sci       Date:  2019-09-30       Impact factor: 5.923

Review 9.  Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy.

Authors:  Fernando de Sá Silva; Paula Nascimento Almeida; João Vitor Paes Rettore; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Gustavo Torres de Souza; Rafaella de Souza Salomão Zanette; Sueli Patricia Harumi Miyagi; Marcelo de Oliveira Santos; Márcia Martins Marques; Carlos Magno da Costa Maranduba
Journal:  J Biomed Biotechnol       Date:  2012-11-20

Review 10.  Enhancing endogenous stem cells in the newborn via delayed umbilical cord clamping.

Authors:  Christopher Lawton; Sandra Acosta; Nate Watson; Chiara Gonzales-Portillo; Theo Diamandis; Naoki Tajiri; Yuji Kaneko; Paul R Sanberg; Cesar V Borlongan
Journal:  Neural Regen Res       Date:  2015-09       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.